These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7284052)

  • 1. The effect of bezofibrate and clofibrate on cholesterol accumulation, esterification and removal in cultured 3T3 fibroblasts.
    Hudson K; Day AJ
    Atherosclerosis; 1981; 40(1):53-63. PubMed ID: 7284052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bezafibrate and clofibrate on cholesterol ester metabolism in rabbit peritoneal macrophages stimulated with acetylated low density lipoproteins.
    Hudson K; Mojumder S; Day AJ
    Exp Mol Pathol; 1983 Feb; 38(1):77-81. PubMed ID: 6832340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bezafibrate and clofibrate on cholesterol ester metabolism in 3T3 cells in smooth muscle cells in tissue culture.
    Hudson K; Day AJ; Marceglia A
    Exp Mol Pathol; 1982 Apr; 36(2):156-63. PubMed ID: 7060720
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of effect of prostaglandins on cholesteryl ester metabolism of 3T3 mouse fibroblasts grown in tissue culture.
    Singh SP; Shamgar FA; Day AJ
    Atherosclerosis; 1982 Mar; 42(1):109-19. PubMed ID: 6952877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bezafibrate and clofibrate on microsomal ACAT and lysosomal cholesterol ester hydrolase activity in the cholesterol-fed rabbit aorta.
    Hudson K; Day AJ
    Atherosclerosis; 1982 Oct; 45(1):109-13. PubMed ID: 7159486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and removal of different cholesterol esters by aortic smooth muscle cells in culture.
    Day AJ; Sheers M
    Atherosclerosis; 1977 Apr; 26(4):483-92. PubMed ID: 857807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
    Ståhlberg D; Angelin B; Einarsson K
    J Lipid Res; 1989 Jul; 30(7):953-8. PubMed ID: 2794793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.
    Vessby B; Lithell H; Hellsing K; Ostlund-Lindqvist AM; Gustafsson IB; Boberg J; Ledermann H
    Atherosclerosis; 1980 Oct; 37(2):257-69. PubMed ID: 7000090
    [No Abstract]   [Full Text] [Related]  

  • 9. Bezafibrate treatment in primary hypercholesterolaemia. Possibility of intermittent treatment.
    Fringes B; Riede UN; von Deimling O
    Atherosclerosis; 1982 Sep; 44(3):391-2. PubMed ID: 7150401
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.
    Shand JH; West DW
    Lipids; 1994 Nov; 29(11):747-52. PubMed ID: 7869854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of uremic hypertriglyceridaemia with bezafibrate.
    Norbeck HE; Anderson P
    Atherosclerosis; 1982 Aug; 44(2):125-36. PubMed ID: 7138614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of cholesterol and triacylglycerol in cultured chick neuronal cells, glial cells, and fibroblasts: accumulation of esterified cholesterol in serum-free culture.
    Saito M; Benson EP; Saito M; Rosenberg A
    J Neurosci Res; 1987; 18(2):319-25. PubMed ID: 3694714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
    Bolzano K; Krempler F; Schellenberg B; Schlierf G
    Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of etofibrate retard, bezafibrate and procetofen.
    Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
    Artery; 1980; 8(2):128-33. PubMed ID: 7458677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K; Djaja S; Richter E
    Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
    Schwandt P; Weisweiler P
    Artery; 1980; 7(6):464-70. PubMed ID: 7236016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hyperlipoproteinaemia in diabetic patients (author's transl)].
    Bruneder H; Klein HJ
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1653-6. PubMed ID: 7308007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.